Matthew Ulman
Overview
Explore the profile of Matthew Ulman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyamoto D, Lee R, Stott S, Ting D, Wittner B, Ulman M, et al.
Cancer Discov
. 2012 Oct;
2(11):995-1003.
PMID: 23093251
Unlabelled: Androgen deprivation therapy (ADT) is initially effective in treating metastatic prostate cancer, and secondary hormonal therapies are being tested to suppress androgen receptor (AR) reactivation in castration-resistant prostate cancer...
2.
Shah A, Yu M, Nakamura Z, Ciciliano J, Ulman M, Kotz K, et al.
Anal Chem
. 2012 Mar;
84(8):3682-8.
PMID: 22414137
Microfluidic systems for affinity-based cell isolation have emerged as a promising approach for the isolation of specific cells from complex matrices (i.e., circulating tumor cells in whole blood). However, these...
3.
Stott S, Lee R, Nagrath S, Yu M, Miyamoto D, Ulkus L, et al.
Sci Transl Med
. 2010 Apr;
2(25):25ra23.
PMID: 20424012
Rare circulating tumor cells (CTCs) are present in the blood of patients with metastatic epithelial cancers but have been difficult to measure routinely. We report a quantitative automated imaging system...
4.
Montagut C, Sharma S, Shioda T, McDermott U, Ulman M, Ulkus L, et al.
Cancer Res
. 2008 Jun;
68(12):4853-61.
PMID: 18559533
Activating BRAF kinase mutations arise in approximately 7% of all human tumors, and preclinical studies have validated the RAF-mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase-ERK signaling cascade as a potentially important...